Robert Olie

Robert Olie serves as Senior Director of Medical Affairs for Hemato-Oncology in Europe at BeiGene. Previously, Robert Olie held the position of Medical Consultant for Voxelotor at Global Blood Therapeutics and served as the European Medical Communications Lead along with various leadership roles in medical communications at Amgen, focusing on hematology, oncology, and biosimilars. Robert Olie's experience includes serving as a Medical Advisor for Oncology-Hematology across Europe, the Middle East, and Africa, and holding senior medical manager and medical manager roles at Janssen, the pharmaceutical division of Johnson & Johnson. Additionally, Robert Olie has a background as a Postdoctoral Researcher at University Hospital Zurich, with a Doctor of Philosophy (PhD) in Tumor Cell Biology earned from Daniel den Hoed Cancer Center/Erasmus University Rotterdam and further education at Universität Ulm and the European School of Oncology.